« Previous
Next »
American Journal of Kidney Diseases
Volume 55, Issue 3
, Pages 570-579
, March 2010
Dosing of Renal Replacement Therapy in Acute Kidney Injury: Lessons Learned From Clinical Trials
References
- Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–2019
- . Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346(5):305–310
- Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20
- . Do we know the optimal dose for renal replacement therapy in the intensive care unit?. Kidney Int. 2006;70(7):1202–1204
- . Reconciling differences in effective solute removal between intermittent and continuous therapies. Semin Dial. 2001;14(4):289–293
- . The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant. 1996;11(8):1574–1581
- Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant. 11998;3(suppl 6):10-14.
- Urea space and total body water measurements by stable isotopes in patients with acute renal failure. Kidney Int. 2004;65(2):725–732
- . Simple and accurate quantification of dialysis in acute renal failure patients during either urea non-steady state or treatment with irregular or continuous schedules. Nephrol Dial Transplant. 2004;19(6):1454–1466
- Measurement of the delivery of dialysis in acute renal failure. Kidney Int. 1999;55(4):1501–1508
- . Renal replacement therapy in acute renal failure: which index is best for dialysis dose quantification?. Int J Artif Organs. 2007;30(3):235–243
- Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356(9223):26–30
- Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters. Nephrol Dial Transplant. 2003;18(5):961–966
- Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol. 2007;18(1):155–164
- Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008;19(7):1360–1370
- . Cascade high volume hemofiltration: preliminary data in septic shock patients. Blood Purif. 2007;25:190;(abstract 14)
- Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 2004;43(3):444–453
- . Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol. 2007;156:387–395
- . Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs. 2005;28(8):777–786
- Pediatric patients with multi-organ dysfunction syndrome receiving continuous renal replacement therapy. Kidney Int. 2005;67(2):653–658
- . Outcome in children receiving continuous venovenous hemofiltration. Pediatrics. 2001;107(6):1309–1312
- . Effect of fluid overload and dose of replacement fluid on survival in hemofiltration. Pediatr Nephrol. 2004;19(12):1394–1399
- Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis. Crit Care Med. 2004;32(8):1771–1776
- . Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant. 1994;13(5):613–617
- . A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12(3):R74
- Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422–427
- . Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30(10):2205–2211
- Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70(7):1312–1317
- . Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008;19(6):1233–1238
- Intensity of continous renal replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627–1638
- . Renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(18):1961–1962
- The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant. 2009;24(7):2179–2186
- . A randomized prospective study comparing high dose continuous venovenous hemodiafiltration (CVVHDF) to standard dose CVVHDF in critically ill patients with acute kidney injury. Blood Purif. 2007;25:193;(abstract 22)
- Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1(5):915–919
- . Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract. 2003;94(4):c94–c98
- . Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure. Clin Trials. 2005;2(5):423–435
- . High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl. 2008;108:S87–S93
- . Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol. 2007;2(4):623–630
- . Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61(6):2235–2239
- . Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int. 1998;53(5):1399–1404
- Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol. 2008;19(5):1034–1040
- A novel selective cytopheretic inhibitory device (SCD) improves mortality in ICU patients with acute kidney injury (AKI) and multiorgan failure (MOF) in a phase II clinical study [abstract]. J Am Soc Nephrol. 2008;19:458A
Originally published online as doi:10.1053/j.ajkd.2009.11.007 on February 1, 2010.
PII: S0272-6386(09)01563-7
doi: 10.1053/j.ajkd.2009.11.007
© 2010 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
American Journal of Kidney Diseases
Volume 55, Issue 3
, Pages 570-579
, March 2010
